Curreio

Curreio is a drug discovery startup company founded in August 2019, specializing in cryo-electron microscopy (cryo-EM) structural analysis technology. Curreio possesses unique technologies and expertise in protein production and purification, grid preparation, and 3D structural analysis, which can be applied to cryo-EM structural analysis at the highest global standards. Currently, we are utilizing cryo-EM technology to develop internal/collaborative drug discovery projects and provide drug discovery support services for pharmaceutical companies. Through structural analysis of challenging proteins and protein supramolecular complexes, we contribute to the world by expanding the possibilities of drug discovery for these targets.